© 2023 MJH Life Sciences and Urology Times. All rights reserved.
© 2023 MJH Life Sciences™ and Urology Times. All rights reserved.
January 31, 2023
The application for darolutamide in the European Union is supported by findings from the phase 3 ARASENS trial.
January 26, 2023
The double-blind phase 3 KEYNOTE-991 trial had enrolled 1251 patients.
January 13, 2023
The SPLASH trial is examining PNT2002 in patients whose tumors express PSMA and who have experienced disease progression on an androgen receptor axis–targeted therapy.
January 10, 2023
At the 2023 SUO Annual Meeting, Grant Stewart, MD, PhD, discussed the potential of neoadjuvant therapy as a tool to help optimize the management of patients with localized kidney cancer.